INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 66 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2016. The put-call ratio across all filers is 21.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $16,000 | -30.4% | 30,000 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $23,000 | -46.5% | 30,000 | 0.0% | 0.00% | -40.0% |
| Q3 2017 | $43,000 | -46.9% | 30,000 | 0.0% | 0.01% | -50.0% |
| Q2 2017 | $81,000 | -33.1% | 30,000 | 0.0% | 0.01% | -37.5% |
| Q1 2017 | $121,000 | -4.0% | 30,000 | 0.0% | 0.02% | -11.1% |
| Q4 2016 | $126,000 | -38.2% | 30,000 | 0.0% | 0.02% | -40.0% |
| Q3 2016 | $204,000 | +9.7% | 30,000 | -6.5% | 0.03% | +7.1% |
| Q2 2016 | $186,000 | -17.0% | 32,100 | 0.0% | 0.03% | -20.0% |
| Q1 2016 | $224,000 | – | 32,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|